1131. Evaluation of drug-drug interaction potential of ensitrelvir for CYP3A by clinical studies and physiologically-based pharmacokinetic model

Name: Work Video:
Duration: 3 min 30 s
Ryosuke Shimizu; Kana Horiuchi; Hiroki Koshimichi; Takanobu Matsuzaki; Shinpei Yoshida; Shingo Sakamoto; Ryuji Kubota
{'id': 'https://openalex.org/W4311744554', 'doi': 'https://doi.org/10.1093/ofid/ofac492.970', 'title': '1131. Evaluation of drug-drug interaction potential of ensitrelvir for CYP3A by clinical studies and physiologically-based pharmacokinetic model', 'display_name': '1131. Evaluation of drug-drug interaction potential of ensitrelvir for CYP3A by clinical studies and physiologically-based pharmacokinetic model', 'publication_year': 2022, 'publication_date': '2022-12-01', 'ids': {'openalex': 'https://openalex.org/W4311744554', 'doi': 'https://doi.org/10.1093/ofid/ofac492.970'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1093/ofid/ofac492.970', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2735126445', 'display_name': 'Open Forum Infectious Diseases', 'issn_l': '2328-8957', 'issn': ['2328-8957'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310311648', 'host_organization_name': 'Oxford University Press', 'host_organization_lineage': ['https://openalex.org/P4310311647', 'https://openalex.org/P4310311648'], 'host_organization_lineage_names': ['University of Oxford', 'Oxford University Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5070169034', 'display_name': 'Ryosuke Shimizu', 'orcid': 'https://orcid.org/0000-0001-9666-8678'}, 'institutions': [{'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Ryosuke Shimizu', 'raw_affiliation_strings': ['Clinical Pharmacology & Pharmacokinetics, Project Management Department , Shionogi & Co., Ltd. Osaka, Japan, Osaka, Osaka , Japan'], 'affiliations': [{'raw_affiliation_string': 'Clinical Pharmacology & Pharmacokinetics, Project Management Department , Shionogi & Co., Ltd. Osaka, Japan, Osaka, Osaka , Japan', 'institution_ids': ['https://openalex.org/I4210118477']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071976641', 'display_name': 'Kana Horiuchi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I88302906', 'display_name': 'Futaba (Japan)', 'ror': 'https://ror.org/03b6zzt23', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I88302906']}, {'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Kana Horiuchi', 'raw_affiliation_strings': ['Laboratory for Drug Discovery and Development , Shionogi & Co., Ltd., Osaka, Japan, Toyonaka, Osaka , Japan'], 'affiliations': [{'raw_affiliation_string': 'Laboratory for Drug Discovery and Development , Shionogi & Co., Ltd., Osaka, Japan, Toyonaka, Osaka , Japan', 'institution_ids': ['https://openalex.org/I88302906', 'https://openalex.org/I4210118477']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070775092', 'display_name': 'Hiroki Koshimichi', 'orcid': 'https://orcid.org/0000-0001-8475-2346'}, 'institutions': [{'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hiroki Koshimichi', 'raw_affiliation_strings': ['Clinical Pharmacology & Pharmacokinetics, Project Management Department , Shionogi & Co., Ltd. Osaka, Japan, Osaka, Osaka , Japan'], 'affiliations': [{'raw_affiliation_string': 'Clinical Pharmacology & Pharmacokinetics, Project Management Department , Shionogi & Co., Ltd. Osaka, Japan, Osaka, Osaka , Japan', 'institution_ids': ['https://openalex.org/I4210118477']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5080055144', 'display_name': 'Takanobu Matsuzaki', 'orcid': 'https://orcid.org/0000-0003-1439-2431'}, 'institutions': [{'id': 'https://openalex.org/I88302906', 'display_name': 'Futaba (Japan)', 'ror': 'https://ror.org/03b6zzt23', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I88302906']}, {'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Takanobu Matsuzaki', 'raw_affiliation_strings': ['Laboratory for Drug Discovery and Development , Shionogi & Co., Ltd., Osaka, Japan, Toyonaka, Osaka , Japan'], 'affiliations': [{'raw_affiliation_string': 'Laboratory for Drug Discovery and Development , Shionogi & Co., Ltd., Osaka, Japan, Toyonaka, Osaka , Japan', 'institution_ids': ['https://openalex.org/I88302906', 'https://openalex.org/I4210118477']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5089714910', 'display_name': 'Shinpei Yoshida', 'orcid': 'https://orcid.org/0000-0002-0004-5845'}, 'institutions': [{'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}, {'id': 'https://openalex.org/I88302906', 'display_name': 'Futaba (Japan)', 'ror': 'https://ror.org/03b6zzt23', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I88302906']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Shinpei Yoshida', 'raw_affiliation_strings': ['Laboratory for Drug Discovery and Development , Shionogi & Co., Ltd., Osaka, Japan, Toyonaka, Osaka , Japan'], 'affiliations': [{'raw_affiliation_string': 'Laboratory for Drug Discovery and Development , Shionogi & Co., Ltd., Osaka, Japan, Toyonaka, Osaka , Japan', 'institution_ids': ['https://openalex.org/I4210118477', 'https://openalex.org/I88302906']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043666689', 'display_name': 'Shingo Sakamoto', 'orcid': 'https://orcid.org/0000-0002-2880-5500'}, 'institutions': [{'id': 'https://openalex.org/I88302906', 'display_name': 'Futaba (Japan)', 'ror': 'https://ror.org/03b6zzt23', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I88302906']}, {'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Shingo Sakamoto', 'raw_affiliation_strings': ['Laboratory for Drug Discovery and Development , Shionogi & Co., Ltd., Osaka, Japan, Toyonaka, Osaka , Japan'], 'affiliations': [{'raw_affiliation_string': 'Laboratory for Drug Discovery and Development , Shionogi & Co., Ltd., Osaka, Japan, Toyonaka, Osaka , Japan', 'institution_ids': ['https://openalex.org/I88302906', 'https://openalex.org/I4210118477']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5074367560', 'display_name': 'Ryuji Kubota', 'orcid': 'https://orcid.org/0000-0003-1979-4472'}, 'institutions': [{'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Ryuji Kubota', 'raw_affiliation_strings': ['Clinical Pharmacology & Pharmacokinetics, Project Management Department , Shionogi & Co., Ltd. Osaka, Japan, Osaka, Osaka , Japan'], 'affiliations': [{'raw_affiliation_string': 'Clinical Pharmacology & Pharmacokinetics, Project Management Department , Shionogi & Co., Ltd. Osaka, Japan, Osaka, Osaka , Japan', 'institution_ids': ['https://openalex.org/I4210118477']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3064, 'currency': 'USD', 'value_usd': 3064, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.262, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.471689, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 60, 'max': 70}, 'biblio': {'volume': '9', 'issue': 'Supplement_2', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10375', 'display_name': 'Pharmacogenetics and Drug Metabolism', 'score': 0.9874, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10375', 'display_name': 'Pharmacogenetics and Drug Metabolism', 'score': 0.9874, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12910', 'display_name': 'Eicosanoids and Hypertension Pharmacology', 'score': 0.9334, 'subfield': {'id': 'https://openalex.org/subfields/1303', 'display_name': 'Biochemistry'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12226', 'display_name': 'Neuroblastoma Research and Treatments', 'score': 0.9301, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/cyp3a', 'display_name': 'CYP3A', 'score': 0.90243626}, {'id': 'https://openalex.org/keywords/midazolam', 'display_name': 'Midazolam', 'score': 0.50203943}, {'id': 'https://openalex.org/keywords/regimen', 'display_name': 'Regimen', 'score': 0.43982324}, {'id': 'https://openalex.org/keywords/pharmacokinetic-interaction', 'display_name': 'Pharmacokinetic interaction', 'score': 0.42149043}], 'concepts': [{'id': 'https://openalex.org/C11824378', 'wikidata': 'https://www.wikidata.org/wiki/Q5014970', 'display_name': 'CYP3A', 'level': 4, 'score': 0.90243626}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.86302114}, {'id': 'https://openalex.org/C185867374', 'wikidata': 'https://www.wikidata.org/wiki/Q2562769', 'display_name': 'Physiologically based pharmacokinetic modelling', 'level': 3, 'score': 0.8451488}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.76961064}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.66356146}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.60315025}, {'id': 'https://openalex.org/C2778000748', 'wikidata': 'https://www.wikidata.org/wiki/Q423071', 'display_name': 'Midazolam', 'level': 3, 'score': 0.50203943}, {'id': 'https://openalex.org/C97320921', 'wikidata': 'https://www.wikidata.org/wiki/Q718753', 'display_name': 'Drug interaction', 'level': 3, 'score': 0.44503415}, {'id': 'https://openalex.org/C2781413609', 'wikidata': 'https://www.wikidata.org/wiki/Q7308373', 'display_name': 'Regimen', 'level': 2, 'score': 0.43982324}, {'id': 'https://openalex.org/C2992379925', 'wikidata': 'https://www.wikidata.org/wiki/Q718753', 'display_name': 'Pharmacokinetic interaction', 'level': 4, 'score': 0.42149043}, {'id': 'https://openalex.org/C526171541', 'wikidata': 'https://www.wikidata.org/wiki/Q407693', 'display_name': 'Cytochrome P450', 'level': 3, 'score': 0.21743843}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.1670742}, {'id': 'https://openalex.org/C62231903', 'wikidata': 'https://www.wikidata.org/wiki/Q1057', 'display_name': 'Metabolism', 'level': 2, 'score': 0.05273816}, {'id': 'https://openalex.org/C2776814716', 'wikidata': 'https://www.wikidata.org/wiki/Q574801', 'display_name': 'Sedation', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1093/ofid/ofac492.970', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2735126445', 'display_name': 'Open Forum Infectious Diseases', 'issn_l': '2328-8957', 'issn': ['2328-8957'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310311648', 'host_organization_name': 'Oxford University Press', 'host_organization_lineage': ['https://openalex.org/P4310311647', 'https://openalex.org/P4310311648'], 'host_organization_lineage_names': ['University of Oxford', 'Oxford University Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.79, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3019463909', 'https://openalex.org/W3004397715', 'https://openalex.org/W2786932006', 'https://openalex.org/W2372482745', 'https://openalex.org/W2114089215', 'https://openalex.org/W2054911076', 'https://openalex.org/W2046948630', 'https://openalex.org/W2043717583', 'https://openalex.org/W2021847316', 'https://openalex.org/W1817672374'], 'abstract_inverted_index': {'Abstract': [0], 'Background': [1], 'Ensitrelvir': [2], 'is': [3, 221, 326, 360], 'a': [4, 222, 363], 'new': [5], 'drug': [6], 'candidate': [7], 'to': [8, 13, 38, 149, 213, 328, 362], 'treat': [9], 'COVID-19': [10], 'disease.': [11], 'According': [12], 'the': [14, 40, 45, 72, 86, 116, 151, 154, 183, 243, 248, 257, 280, 291, 296, 303, 323, 330, 341], 'in': [15], 'vitro': [16], 'drug-drug': [17], 'interaction': [18], '(DDI)': [19], 'study,': [20], 'time-dependent': [21], 'inhibition': [22], 'by': [23, 51, 210, 300, 307], 'ensitrelvir': [24, 43, 70, 108, 168, 207, 220, 246, 278, 294, 310, 339, 359], 'was': [25, 37, 91, 94, 208, 239, 252, 269, 284], 'observed': [26], 'on': [27, 44, 75, 85, 96, 115, 139, 182, 236, 247, 266, 279], 'cytochrome': [28], 'P450': [29], '3A': [30], '(CYP3A).': [31], 'The': [32, 63, 101, 161, 201, 232, 262, 286, 334, 354], 'purpose': [33], 'of': [34, 42, 48, 65, 69, 88, 103, 107, 118, 157, 163, 167, 185, 203, 215, 234, 245, 250, 260, 264, 277, 282, 293, 298, 305, 343, 366], 'this': [35], 'study': [36, 319, 336], 'evaluate': [39, 150], 'effect': [41, 64, 244, 276], 'pharmacokinetics': [46], '(PK)': [47], 'CYP3A': [49, 132, 186, 224, 344, 367], 'substrates': [50, 187, 345], 'clinial': [52], 'DDI': [53], 'studies': [54], 'and': [55, 99, 121, 135, 147, 242, 272, 302], 'physiologically-based': [56], 'pharmacokinetic': [57], '(PBPK)': [58], 'analyses.': [59], 'Methods': [60], 'Clinical': [61], 'studies:': [62], 'once': [66, 104, 164], 'daily': [67, 105, 165], 'multiple-doses': [68, 106, 166], 'with': [71, 109, 144, 169, 206, 226, 320, 346, 368], 'loading': [73, 174], 'dose': [74, 79, 156, 171, 176, 259], 'Day': [76, 237, 267], '1/': [77], 'maintenance': [78], '(750/250': [80], 'mg)': [81], 'for': [82, 112, 179, 229, 314, 349, 371], '6': [83, 230, 352], 'days': [84, 114], 'PK': [87, 117, 184, 249, 281, 342], 'midazolam': [89], '(MDZ)': [90], 'assessed.': [92], 'MDZ': [93, 204, 216, 299, 321], 'administered': [95, 138], 'Days': [97, 140], '-2': [98], '6.': [100], 'effects': [102, 152, 162], '750/250': [110, 227, 347], 'mg': [111, 228, 313, 348, 370], '5': [113, 142, 180, 238, 268, 315, 350, 372], 'dexamethasone': [119], '(DXS)': [120], 'prednisolone': [122], '(PLS)': [123], 'were': [124, 130, 137, 188], 'also': [125, 131], 'assessed': [126], 'because': [127], 'these': [128], 'corticosteroids': [129], 'substrates.': [133], 'DXS': [134, 235, 251, 306], 'PLS': [136, 265, 283], '-2,': [141], '(co-administration': [143], 'ensitrelvir),': [145], '9': [146], '14': [148], 'after': [153, 256], 'last': [155, 258], 'ensitrelvir.': [158, 261], 'PBPK': [159, 192, 287, 331, 355], 'analyses:': [160], 'another': [170], 'regimen': [172], '(the': [173], 'dose/mentenance': [175], '[375/125': [177], 'mg]': [178], 'days)': [181], 'predicted': [189, 289], 'using': [190], 'Simcyp': [191], 'Simulator': [193], '(Version': [194], '20,': [195], 'Certara': [196], 'UK': [197], 'Limited,': [198], 'UK).': [199], 'Results': [200], 'AUC0-inf': [202, 233, 263], 'co-administered': [205], 'increased': [209, 240, 270, 295], '8.80-fold': [211], 'compared': [212], 'those': [214], 'alone,': [217], 'indicating': [218], 'that': [219, 290, 338, 358], 'strong': [223], 'inhibitor': [225, 365], 'days.': [231, 316, 353, 373], '3.47-fold': [241], 'diminished': [253], 'over': [254], 'time': [255], '1.25-fold': [271], 'no': [273], 'clinically': [274], 'meaningful': [275], 'observed.': [285], 'analyses': [288, 324, 356], 'co-administration': [292], 'AUC': [297, 304], '3.83-fold': [301], '2.49-fold': [308], 'following': [309], 'at': [311], '375/125': [312, 369], 'A': [317], 'clinical': [318, 335], 'under': [322], 'conditions': [325], 'underway': [327], 'confirm': [329], 'results.': [332], 'Conclusion': [333], 'revealed': [337], 'affects': [340], 'or': [351], 'suggests': [357], 'expected': [361], 'moderate': [364], 'Disclosures': [374], 'Ryosuke': [375], 'Shimizu,': [376], 'Shionogi': [377, 384, 392, 400, 408, 416, 424], '&amp;': [378, 385, 393, 401, 409, 417, 425, 429], 'Co.,': [379, 386, 394, 402, 410, 418, 426, 430], 'Ltd.:': [380, 387, 395, 403, 411, 419, 427, 431], 'employee': [381, 388, 396, 412, 420], 'Kana': [382], 'Horiuchi,': [383], 'Hiroki': [389], 'Koshimichi,': [390], 'n/a,': [391, 415], 'Takanobu': [397], 'Matsuzaki,': [398], 'Ph.D.,': [399, 407, 423], 'Employee': [404], 'Shinpei': [405], 'Yoshida,': [406], 'Shingo': [413], 'Sakamoto,': [414], 'Ryuji': [421], 'Kubota,': [422], 'employee|Shionogi': [428], 'employee.': [432]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4311744554', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}], 'updated_date': '2024-12-11T21:56:10.818787', 'created_date': '2022-12-28'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
